Authors:
GARBESI A
HAMY F
MAFFINI M
ALBRECHT G
KLIMKAIT T
Citation: A. Garbesi et al., TAR-RNA BINDING BY HIV-1 TAT PROTEIN IS SELECTIVELY INHIBITED BY ITS L-ENANTIOMER, Nucleic acids research, 26(12), 1998, pp. 2886-2890
Authors:
KLIMKAIT T
STAUFFER F
LUPO E
SONDEREGGERRUBLI C
Citation: T. Klimkait et al., DISSECTING THE MODE OF ACTION OF VARIOUS HIV-INHIBITOR CLASSES IN A STABLE CELLULAR-SYSTEM, Archives of virology, 143(11), 1998, pp. 2109-2131
Authors:
BOLD G
FASSLER A
CAPRARO HG
COZENS R
KLIMKAIT T
LAZDINS J
MESTAN J
PONCIONI B
ROSEL J
STOVER D
TINTELNOTBLOMLEY M
ACEMOGLU F
BECK W
BOSS E
ESCHBACH M
HURLIMANN T
MASSO E
ROUSSEL S
UCCISTOLL K
WYSS D
LANG R
Citation: G. Bold et al., NEW AZA-DIPEPTIDE ANALOGS AS POTENT AND ORALLY ABSORBED HIV-1 PROTEASE INHIBITORS - CANDIDATES FOR CLINICAL DEVELOPMENT, Journal of medicinal chemistry, 41(18), 1998, pp. 3387-3401
Authors:
HAMY F
FELDER ER
HEIZMANN G
LAZDINS J
ABOULELA F
VARANI G
KARN J
KLIMKAIT T
Citation: F. Hamy et al., AN INHIBITOR OF THE TAT TAR RNA INTERACTION THAT EFFECTIVELY SUPPRESSES HIV-1 REPLICATION/, Proceedings of the National Academy of Sciences of the United Statesof America, 94(8), 1997, pp. 3548-3553
Authors:
LAZDINS JK
MESTAN J
GOUTTE G
WALKER MR
BOLD G
CAPRARO HG
KLIMKAIT T
Citation: Jk. Lazdins et al., IN-VITRO EFFECT OF ALPHA(1)-ACID GLYCOPROTEIN ON THE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY OF THE PROTEASE INHIBITOR CGP-61755 -A COMPARATIVE-STUDY WITH OTHER RELEVANT HIV PROTEASE INHIBITORS, The Journal of infectious diseases, 175(5), 1997, pp. 1063-1070
Authors:
FACKLER OT
KIENZLE N
KREMMER E
BOESE A
SCHRAMM B
KLIMKAIT T
KUCHERER C
MUELLERLANTZSCH N
Citation: Ot. Fackler et al., ASSOCIATION OF HUMAN-IMMUNODEFICIENCY-VIRUS NEF PROTEIN WITH ACTIN ISMYRISTOYLATION DEPENDENT AND INFLUENCES ITS SUBCELLULAR-LOCALIZATION, European journal of biochemistry, 247(3), 1997, pp. 843-851
Authors:
LAZDINS JK
BOLD G
CAPRARO HG
COZENS R
FASSLER A
FLESCH G
KLIMKAIT T
LANG M
MESTAN J
PONCIONI B
ROSEL J
STOVER D
TINTELNOTBLOMLEY M
WALKER MR
WOODSCOOK K
Citation: Jk. Lazdins et al., PROFILE OF CGP-61755 - A NOVEL AND POTENT HIV-1 PROTEASE INHIBITOR THAT SHOWS ENHANCED ANTI-HIV ACTIVITY WHEN COMBINED WITH OTHER ANTIRETROVIRAL AGENTS IN-VITRO, Schweizerische medizinische Wochenschrift, 126(43), 1996, pp. 1849-1851
Authors:
WYATT JR
VICKERS TA
ROBERSON JL
BUCKHEIT RW
KLIMKAIT T
DEBAETS E
DAVIS PW
RAYNER B
IMBACH JL
ECKER DJ
Citation: Jr. Wyatt et al., COMBINATORIALLY SELECTED GUANOSINE-QUARTET STRUCTURE IS A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE-MEDIATED CELL-FUSION, Proceedings of the National Academy of Sciences of the United Statesof America, 91(4), 1994, pp. 1356-1360
Authors:
ALTERI E
BOLD G
COZENS R
FAESSLER A
KLIMKAIT T
LANG M
LAZDINS J
PONCIONI B
ROESEL JL
SCHNEIDER P
WALKER M
WOODSCOOK K
Citation: E. Alteri et al., CGP-53437, AN ORALLY BIOAVAILABLE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE WITH POTENT ANTIVIRAL ACTIVITY, Antimicrobial agents and chemotherapy, 37(10), 1993, pp. 2087-2092